RBC Europe’s Axonics, Inc. Common Stock AXNX Stock Holding History

RBC Europe’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-930	Closed	-$60.5K	–	1198
2021 Q3	$60.5K	Hold	930	–	–	﹤0.01%	537
2021 Q2	$59K	Buy	+930	New	+$54.9K	﹤0.01%	552

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RBC Europe's AXNX Position: Q4 2021 in Review

RBC Europe sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2021, closing a stake of 930 shares — an estimated $60.5K sold.

RBC Europe first reported a position in AXNX in Q2 2021 and held it in 2 quarters. The position peaked at $60.5K in Q3 2021. 180 funds tracked by Wall St. Rank hold AXNX as of Q4 2021.

RBC Europe reported no remaining Axonics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 930 Axonics, Inc. Common Stock shares in Q4 2021, an estimated $60.5K.
RBC Europe first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
RBC Europe's Axonics, Inc. Common Stock position peaked at $60.5K in Q3 2021.
180 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.